Sign up
Log in
12 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • Intensity Therapeutics (NASDAQ:INTS) stock increased by 277.7% to $1.01 during Thursday's regular session. The market value of their outstanding shares is at $13.0 million.
  • Harvard Bioscience (NASDAQ:HBIO) shares moved upwards by 51.98% to $0.68. The market value of their outstanding shares is at $19.8 million.
  • Emergent BioSolutions (NYSE:EBS) stock increased by 32.87% to $12.49. The company's market cap stands at $510.2 million. The company's, Q3 earnings came out yesterday.
  • Guardant Health (NASDAQ:GH) shares rose 30.11% to $94.03. The market value of their outstanding shares is at $9.0 billion. As per the press release, Q3 earnings came out yesterday.
  • Advanced Biomed (NASDAQ:ADVB) stock moved upwards by 29.58% to $0.59. The company's market cap stands at $9.8 million.
  • Metsera (NASDAQ:MTSR) shares rose 24.9% to $65.21. The market value of their outstanding shares is at $5.4 billion.

Losers

  • CERo Therapeutics Hldgs (NASDAQ:CERO) stock declined by 88.8% to $0.2 during Thursday's regular session. The market value of their outstanding shares is at $3.3 million.
  • MSP Recovery (NASDAQ:MSPR) shares fell 38.35% to $0.37.
  • Integra Lifesciences (NASDAQ:IART) stock declined by 26.25% to $11.38. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q3 earnings came out today.
  • Apellis Pharmaceuticals (NASDAQ:APLS) stock decreased by 24.56% to $22.67. The market value of their outstanding shares is at $3.7 billion. The company's, Q3 earnings came out today.
  • Veru (NASDAQ:VERU) stock declined by 18.58% to $2.85. The company's market cap stands at $51.2 million.
  • Apollomics (NASDAQ:APLM) shares declined by 17.86% to $11.59. The company's market cap stands at $30.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.